Cargando…
Targeting N-myristoylation for therapy of B-cell lymphomas
Myristoylation, the N-terminal modification of proteins with the fatty acid myristate, is critical for membrane targeting and cell signaling. Because cancer cells often have increased N-myristoyltransferase (NMT) expression, NMTs were proposed as anti-cancer targets. To systematically investigate th...
Autores principales: | Beauchamp, Erwan, Yap, Megan C., Iyer, Aishwarya, Perinpanayagam, Maneka A., Gamma, Jay M., Vincent, Krista M., Lakshmanan, Manikandan, Raju, Anandhkumar, Tergaonkar, Vinay, Tan, Soo Yong, Lim, Soon Thye, Dong, Wei-Feng, Postovit, Lynne M., Read, Kevin D., Gray, David W., Wyatt, Paul G., Mackey, John R., Berthiaume, Luc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582192/ https://www.ncbi.nlm.nih.gov/pubmed/33093447 http://dx.doi.org/10.1038/s41467-020-18998-1 |
Ejemplares similares
-
P465: N-MYRISTOYLATION INHIBITION ABROGATES OXIDATIVE PHOSPHORYLATION TO TARGET ACUTE MYELOID LEUKEMIA STEM CELLS
por: Gamma, Jay, et al.
Publicado: (2023) -
H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions
por: Cai, Yichao, et al.
Publicado: (2021) -
GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer
por: Shin, Eun Myoung, et al.
Publicado: (2021) -
Myristoylation versus SRP
por: LeBrasseur, Nicole
Publicado: (2005) -
GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers
por: Rasheed, Suhail Ahmed Kabeer, et al.
Publicado: (2017)